![Real-world practice patterns and outcomes in Veterans with relapsed/refractory diffuse large B-cell lymphoma | Future Oncology Real-world practice patterns and outcomes in Veterans with relapsed/refractory diffuse large B-cell lymphoma | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon-2020-0522/asset/images/medium/figure3.gif)
Real-world practice patterns and outcomes in Veterans with relapsed/refractory diffuse large B-cell lymphoma | Future Oncology
![Overall survival of patients with diffuse large B-cell lymphoma after... | Download Scientific Diagram Overall survival of patients with diffuse large B-cell lymphoma after... | Download Scientific Diagram](https://www.researchgate.net/publication/330523075/figure/fig5/AS:717559355682821@1548090890581/Overall-survival-of-patients-with-diffuse-large-B-cell-lymphoma-after-rituximab.png)
Overall survival of patients with diffuse large B-cell lymphoma after... | Download Scientific Diagram
![A model to predict the prognosis of diffuse large B-cell lymphoma based on ultrasound images | Scientific Reports A model to predict the prognosis of diffuse large B-cell lymphoma based on ultrasound images | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-023-30533-y/MediaObjects/41598_2023_30533_Fig3_HTML.png)
A model to predict the prognosis of diffuse large B-cell lymphoma based on ultrasound images | Scientific Reports
![Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone](https://www.spandidos-publications.com/article_images/ol/15/3/ol-15-03-3602-g00.jpg)
Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone
Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role? | Haematologica
![Blood Journal on X: "Limited-stage diffuse large B-cell lymphoma https://t.co/ujdkUK6IrM https://t.co/MjOVxXrUGq" / X Blood Journal on X: "Limited-stage diffuse large B-cell lymphoma https://t.co/ujdkUK6IrM https://t.co/MjOVxXrUGq" / X](https://pbs.twimg.com/media/FLV7IScXwAErwcF.jpg:large)
Blood Journal on X: "Limited-stage diffuse large B-cell lymphoma https://t.co/ujdkUK6IrM https://t.co/MjOVxXrUGq" / X
Analysis of Growth in the Diffuse Large B-Cell Lymphoma Treatment Market: Forecasting Demand, Trends, and
![Progression-free survival and overall survival rates of DLBCL patients,... | Download Scientific Diagram Progression-free survival and overall survival rates of DLBCL patients,... | Download Scientific Diagram](https://www.researchgate.net/publication/294256802/figure/fig1/AS:560859506110464@1510730734564/Progression-free-survival-and-overall-survival-rates-of-DLBCL-patients-according-to.png)
Progression-free survival and overall survival rates of DLBCL patients,... | Download Scientific Diagram
![Real-World Eligibility for Second-Line Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma: A Population-Based Analysis - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Real-World Eligibility for Second-Line Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma: A Population-Based Analysis - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and](https://www.astctjournal.org/cms/asset/d0451282-f5c1-4aa3-969c-af222fa572ba/gr1.jpg)
Real-World Eligibility for Second-Line Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma: A Population-Based Analysis - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and
![Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden | Blood Cancer Journal Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-020-00403-1/MediaObjects/41408_2020_403_Fig1_HTML.png)
Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden | Blood Cancer Journal
![Cancers | Free Full-Text | Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab Cancers | Free Full-Text | Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab](https://www.mdpi.com/cancers/cancers-14-01917/article_deploy/html/images/cancers-14-01917-g001.png)
Cancers | Free Full-Text | Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab
![Evaluation of treatment patterns and survival among patients with diffuse large B-cell lymphoma in the USA | Future Oncology Evaluation of treatment patterns and survival among patients with diffuse large B-cell lymphoma in the USA | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon-2018-0788/asset/images/medium/figure3.gif)
Evaluation of treatment patterns and survival among patients with diffuse large B-cell lymphoma in the USA | Future Oncology
![A) Overall survival of 112 patients with relapsed diffuse large B-cell... | Download Scientific Diagram A) Overall survival of 112 patients with relapsed diffuse large B-cell... | Download Scientific Diagram](https://www.researchgate.net/publication/266324247/figure/fig1/AS:392151134425103@1470507524643/A-Overall-survival-of-112-patients-with-relapsed-diffuse-large-B-cell-lymphoma-DLBCL.png)